Intranasal Droplets and Sprays Could Help Tackle SARS-CoV-2 : Researchers from Freie Universität Berlin and the University of Bern have published the results of a groundbreaking study

Scientists at Freie Universität Berlin (Germany) and the University of Bern (Switzerland) have developed highly effective SARS-CoV-2 preclinical vaccine candidates that can be administered in the form of nasal drops or sprays. Preclinical studies in hamsters demonstrated that the vaccine candidates induce robust neutralizing antibodies and prevent SARS-CoV-2 replication as well as signs of Covid-19. The findings were recently published in an article titled “Development of Safe and Highly Protective Live-Attenuated SARS-CoV-2 Vaccine Candidates by Genome Recoding” in the journal Cell Reports. [...] Alongside Freie Universität Berlin, project partners include the Institute of Virology and Immunology (IVI) headed by Professor Volker Thiel, the University of Bern led by Professor Sebastian Leidel, the University of Geneva whose research team is managed by Professor Ramesh Pillai, and the Friedrich Loeffler Institute on the island of Riems directed by Professor Martin Beer.